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Abstract
Background: PubChem is an open repository for small molecules and their experimental biological activity.
PubChem integrates and provides search, retrieval, visualization, analysis, and programmatic access tools in an
effort to maximize the utility of contributed information. There are many diverse chemical structures with similar
biological efficacies against targets available in PubChem that are difficult to interrelate using traditional 2-D
similarity methods. A new layer called PubChem3D is added to PubChem to assist in this analysis.
Description: PubChem generates a 3-D conformer model description for 92.3% of all records in the PubChem
Compound database (when considering the parent compound of salts). Each of these conformer models is
sampled to remove redundancy, guaranteeing a minimum (non-hydrogen atom pair-wise) RMSD between
conformers. A diverse conformer ordering gives a maximal description of the conformational diversity of a
molecule when only a subset of available conformers is used. A pre-computed search per compound record gives
immediate access to a set of 3-D similar compounds (called “Similar Conformers”) in PubChem and their respective
superpositions. Systematic augmentation of PubChem resources to include a 3-D layer provides users with new
capabilities to search, subset, visualize, analyze, and download data.
A series of retrospective studies help to demonstrate important connections between chemical structures and their
biological function that are not obvious using 2-D similarity but are readily apparent by 3-D similarity.
Conclusions: The addition of PubChem3D to the existing contents of PubChem is a considerable achievement,
given the scope, scale, and the fact that the resource is publicly accessible and free. With the ability to uncover
latent structure-activity relationships of chemical structures, while complementing 2-D similarity analysis
approaches, PubChem3D represents a new resource for scientists to exploit when exploring the biological
annotations in PubChem.
Background
PubChem [1-4](http://pubchem.ncbi.nlm.nih.gov) is an
open repository for small molecules and their experi-
mental biological activities. The primary goal of Pub-
C h e mi st ob eap u b l i cr e s o u r c ec o n t a i n i n g
comprehensive information on the biological activities
of small molecules. PubChem provides search, retrieval,
visualization, analysis, and programmatic access tools in
an effort to maximize the utility of contributed informa-
tion. The PubChem3D project adds a new layer to this
infrastructure. In the most basic sense, PubChem3D
[5-10] generates a 3-D conformer model description of
the small molecules contained within the PubChem
Compound database. This 3-D description can be
employed to enhance existing PubChem search and ana-
lysis methodologies by means of 3-D similarity. Prior to
PubChem3D, this similarity approach was limited to a
2-D dictionary-based fingerprint (ftp://ftp.ncbi.nlm.nih.
gov/pubchem/specifications/pubchem_fingerprints.txt)
to help relate chemical structures. With the advent of
PubChem3D, this is now expanded to use a Gaussian-
based similarity description of molecular shape [11-13]
used in software packages such as ROCS [14] and
OEShape [15] from OpenEye Scientific Software, Inc.
It is reasonable to ask, why do we consider 3-D simi-
larity methodologies at all? To put it simply, 2-D meth-
ods, while very useful and far cheaper computationally,
may not be enough. A pitfall of most 2-D similarity
methods is a general lack of ability to relate chemically
diverse molecules with similar biological efficacy and
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appropriate 3-D shape and possesses compatible func-
tional groups properly oriented in 3-D space, it will
likely bind to the biological moiety of interest. This
“lock and key” binding motif is a major premise of
structure-based drug design, docking, and molecular
modelling applied with varying degrees of success over
the past twenty years or more [16-23]. These “compati-
ble functional groups” involved in binding small mole-
cules to proteins, which are typically used to define
pharmacophores, are referred to here simply as “fea-
tures”. Therefore, in this context, 3-D similarity consid-
ering both shape and feature complementariness may be
useful to find or relate chemical structures that may
bind similarly to a protein target.
In its essence, 3-D similarity adds another dimension
to data mining and it can provide some degree of ortho-
gonality from 2-D similarity results. With 2-D similarity,
one can typically see by eye increased changes in the
chemical structure molecular graph with increasing dis-
similarity [8,10]. With 3-D similarity, it is not always
obvious by looking only at the molecular graph, often
requiring one to visualize 3-D conformer alignments to
relate diverse chemistries. In all, 3-D similarity is com-
plementary to 2-D similarity and provides an easy-to-
grasp understanding (i.e., one can readily see by examin-
ing a conformer pair superposition that both shape and
features are similar) that may help to provide a contrast
or new insight to the same (biological) data.
This work gives an overview of the PubChem3D pro-
ject and its current capabilities. The technology and
background that allowed 3-D methodologies to be eco-
nomically applied to the tens of millions of chemical
structures in the PubChem Compound database are
described elsewhere [5-10] covering various aspects of
the project, including conformer model generation vali-
dation [6], the relative uniqueness of molecular shape
[7], and 3-D neighboring methodology [8].
Construction and Content
1. PubChem3D Coverage
As one can imagine, it does not make sense nor is it
possible to compute a 3-D description for all chemical
structures in PubChem (e.g., complexes and mixtures).
PubChem provides a 3-D conformer model description
for each record in the PubChem Compound database
that satisfies the following conditions:
(1) Not too large (with ≤ 50 non-hydrogen atoms).
(2) Not too flexible (with ≤ 15 rotatable bonds).
(3) Consists of only supported elements (H, C, N, O,
F, Si, P, S, Cl, Br, and I).
(4) Has only a single covalent unit (i.e., not a salt or
a mixture).
(5) Contains only atom types recognized by the
MMFF94s force field [24-26].
(6) Has fewer than six undefined atom or bond
stereo centers.
Figure 1 shows the PubChem3D coverage as of June
2011. Out of more than 30.3 million chemical structure
records in the PubChem Compound database, there are
nearly 27.2 million records with a 3-D description. This
represents 89.6% of the PubChem Compound contents
(92.3% when considering that 2.7% are salts whose par-
ent structure has a 3-D description). Of the remaining
7.7% of chemical structures in PubChem devoid of a 3-
D description, the largest category (representing 1.48
million or 4.9% of the total archive) consists of struc-
tures with more than 15 rotatable bonds. The next lar-
gest unique count (i.e., those not already represented by
structures with more than 15 rotatable bonds) is the
cases of MMFF94s non-supported elements and non-
supported atom environments (representing 280 thou-
sand or 0.9% of the total archive, with an overlapping
absolute count of 389 thousand). The remaining unique
counts are the cases of large structures with +50 non-
hydrogen atoms (representing 253 thousand or 0.8% of
the total archive, with an overlapping absolute count of
882 thousand), excessive undefined stereo (representing
129 thousand or 0.4% of the total archive, with an over-
lapping absolute count of 234 thousand), chemical
structures involving complexes or mixtures (represent-
ing 105 thousand or 0.3% of the total archive, with an
overlapping absolute count of 324 thousand), and con-
former generation failure (representing 79 thousand or
0.3% of the total archive). While the reasons for missing
Figure 1 PubChem Compound database 3-D coverage.A so n e
can see, 89.6% of all records have a 3-D conformer model. If one
includes the parent compound of salts, this coverage can be
considered to be 92.3%. Of the cases not having a 3-D conformer
model, the majority are due to the flexibility of the chemical
structure being too great to be suitable for conformer generation.
Bolton et al. Journal of Cheminformatics 2011, 3:32
http://www.jcheminf.com/content/3/1/32
Page 2 of 15a 3-D description categories sometimes overlap, the
ordering above is such that the one with the largest
overall population is chosen first, with each subsequent
category picking the largest remaining unique subpopu-
lation not already covered, until all categories were
exhausted.
2. Conformer Models
The computed coordinates for the 3-D representations
are the essence of the PubChem3D project. Creation of
the stored conformational models consists of multistep
processes involving separate conformer generation, sam-
pling, and post processing steps.
All conformers were generated by the OpenEye Scien-
tific Software, Inc., OMEGA software [27-31] using the
C++ interface, the MMFF94s force field [24-26] minus
coulombic terms, and an energy filter of 25 kcal/mol.
(Removal of coulombic terms [6,32-35] eliminated a bias
towards conformations with energy-lowering intra-mole-
cular interactions that tend not to be important for
inter-molecular interactions, an important consideration
given that the 3-D coordinates are generated in vacuo.
Removal of attractive van der Waals terms did not have
any noticeable effect [6].) A maximum of 100,000 con-
formers per chemical structure stereo isomer were
allowed. When undefined stereo centers were present,
each stereo isomer was enumerated and conformers
independently generated. These stereo isomer confor-
mers were then combined (2**5 = 32 maximum stereo
permutations, 32 * 100,000 = maximum 3.2 million
conformers).
Limiting to 100,000 conformations per stereo isomer
can be a significant factor in limiting exploration of the
conformational space. Ideally, one would want to
explore the conformational space of a molecule exhaus-
tively. In reality, it is not tractable to do so. For exam-
ple, if one considers only three angles per rotatable
bond and there are eleven rotatable bonds, this would
yield 3**11 (= 177,147) possible conformers. If one con-
siders four torsion angles per rotatable bond, and there
are nine rotatable bonds, this would yield 4**9 (=
262,144) possible conformers. One can see how quickly
systematic approaches can run into trouble with such
exponential growth in the count of conformations and
w h yt h e r ei sal i m i to nh o wf l e x i b l eam o l e c u l ei s
allowed to be.
With conformers generated, another important con-
sideration is immediately obvious. It is not practical to
store many thousands of conformers per compound.
Therefore, after conformer generation is complete, the
conformation count is reduced by sampling using root-
mean-square-distance (RMSD) of pair-wise comparison
of non-hydrogen atomic coordinates using the OEChem
[36] OERMSD function with the automorph detection
(which considers local symmetry equivalence of atoms
such that, for example, rotation of a phenyl ring does
not yield an artificially high RMSD) and overlay (which
minimizes RMSD between conformers by rotation and
translation of one conformer to the other) options
selected. In some rare cases, the automorph detection
was prohibitively expensive computationally and not
used.
The sampling procedure employed is described else-
where [7] but involves a two-stage clustering approach
with an initial pass to partition-cluster conformers using
an exclusion region hierarchy of decreasing dissimilarity
(NlogN computational complexity, each cluster repre-
sentative forms an exclusion region at a particular
RMSD), followed by a step to remove edge-effects from
the partition clustering (N
2 computational complexity
using only the cluster representatives at the desired
RMSD). The RMSD value used when sampling was
dependent on the size and flexibility of the chemical
structure.
Equations 1 and 2 were developed [6] to help prevent
using a conformer sampling RMSD that was less than
the capability of the OMEGA software to reproduce
bioactive ligand conformations. The equations were
intended to ensure that 90% of the sampled conformer
models of 25,972 small-molecule ligands, whose 3-D
structures were experimentally determined, should con-
tain at least one conformer within the RMSD sampling
value to a bioactive conformation. The resulting
RMSD_pred value was rounded to the nearest 0.2 incre-
ment. The smallest RMSD value used was 0.4. If more
than 500 conformers resulted after sampling, the RMSD
was incremented by a further 0.2 and the conformer
model was re-clustered. This process was repeated as
many times as necessary to restrict the overall count of
conformers to be 500 or less.
RMSD pred = 0.219 + 0.0099 × nha + 0.040 × er (1)
where “nha“ is the count of non-hydrogen atoms in
the molecule, “er“ i st h ee f f e c t i v er o t o rc o u n t ,a n d
“RMSD_pred“ is the predicted average accuracy for a
given “nha“ and “er“ value.
er = rb + nara/5 (2)
where “er“ is the effective rotor count, “rb“ is the rota-
table bond count (computed using the OEChem “IsRo-
tor” function) and “nara“ is the count of non-aromatic
ring atom count (OEChem OpenEye aromaticity model)
excluding bridgehead atoms and SP2 hybridized atoms.
A post processing step was performed, after confor-
mer model RMSD sampling, to completely relax the
hydrogen atom locations by performing a full energy
minimization where all non-hydrogen atoms were kept
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formers that had MMFF94 atom-atom interactions
greater than 25 kcal/mol. Finally, each conformer was
rotated and translated to their principal steric axes (i.e.,
non-mass weighted principal moments of inertia axes)
considering only non-hydrogen atoms.
It is important to note that the conformers produced
are not stationary points on a potential energy hypersur-
face. In fact, one can readily achieve lower-energy con-
formations of a given chemical structure by performing
an all-atom energy minimization to remove any bond,
angle, or torsion strain present in vacuo. The Pub-
Chem3D conformer model for a chemical structure is
meant to represent all possible biologically-relevant con-
formations that the molecule may have. In theory, one
should have a reasonable chance to find any biologically
accessible conformation within the RMSD sampling dis-
tance of the conformer model.
3. Conformer Model Properties
After a conformer model is produced, a series of prop-
erties are computed for each compound and each asso-
ciated conformer. Table 1 lists the compound- and
conformer-level properties provided by PubChem3D.
The compound properties include: the sampling RMSD
used to construct the conformer model; the MMFF94
partial charges per atom [36]; the functional group
atoms that define each pharmacophore feature [15]; and
the diverse conformer ordering, always starting with the
default conformer per compound.
The feature definition lists the set of non-hydrogen
atoms that comprise a given fictitious feature atom. The
feature definitions are computed using the OEShape
“ImplicitMillsDeans” forcefield [15,37]. Care is taken to
(iteratively) merge feature definitions of common type
that are within 1.0 Å distance of each other. Each fea-
ture definition is used to generate a fictitious “color”
atom, whose 3-D coordinates are at the steric center of
the atoms that comprise it (i.e., at the average {X, Y, Z}
value). There are six feature types used: anion, cation,
(hydrogen-bond) acceptor, (hydrogen-bond) donor,
hydrophobe, and ring.
The conformer properties include: the global confor-
mer identifier (GID); conformer volume [15]; steric
shape moments (monopole, quadrupole {Qx,Q y,Q z},
and octopole {Oxxx,O yyy,O zzz,O xxy,O xxz,O yyx,O yyz,
Ozzx,O zzy,a n dO xyz}) [15]; shape self-overlap volume
used in shape similarity computations [11]; feature self-
overlap volume used in feature similarity computations
[11]; MMFF94s energy with coulombic terms removed
[38]; and the PubChem shape fingerprint [8].
ST =
VAB
VAA + VBB − VAB
(3)
where ST is the measure of shape similarity (shape
Tanimoto), VAA and VBB are the respective self-overlap
volume of conformers A and B, and VAB is the common























where CT is the measure of feature similarity (color
Tanimoto), the index “f“ indicates any of the six inde-





the respective self-overlap volumes of conformers A and
B for feature atom type f, and V
f
AB is the overlap volume
of conformers A and B for feature type f.
ComboT = ST + CT (5)
where ComboT is the combo Tanimoto, ST is the
shape Tanimoto, and CT is the color Tanimoto.
A diverse ordering of conformers is provided for each
compound conformer ensemble [8,39,40]. Using the
lowest energy conformer in the ensemble as the initial
default conformer, the conformer most dissimilar to the
first is selected as the second diverse conformer. The
conformer most dissimilar to the first two dissimilar
conformers is chosen as the third diverse conformer.
This process is repeated until there are no more confor-
mers to be assigned a dissimilarity ordering. Similarity is
measured by ST (Equation 3)a n dC T( Equation 4),
involving a conformer superposition optimization
[11,36] to maximize the shape volume overlap between
two conformers by means of rotation and translation of
one conformer to the other. This is followed by a single
point CT computation at the ST-optimized conformer
pair overlay. The ST and CT are then added to yield a





MMFF94 partial charges X
Pharmacophore features X
Conformer model sampling RMSD X
Diverse conformer ordering X
Conformer identifier X
MMFF94s Energy (minus coulombic terms) X
Conformer volume X
Steric shape moments X
Shape self-overlap volume X
Feature self-overlap volume X
Shape fingerprint X
Compound- and conformer-specific properties available for PubChem
Compound records.
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smallest sum of combo Tanimoto to all assigned dissim-
ilar conformers is selected ast h en e x tm o s td i s s i m i l a r .
In the case of a tie, the one with the largest sum of
combo Tanimoto to unassigned conformers is used.
Note that PubChem has another source of 3-D infor-
mation of small molecules, besides PubChem3D. The
PubChem Substance database (unique identifier: SID)
contains 3-D structures of small molecules deposited
from individual depositors, which can be either experi-
mentally determined or computationally predicted. For
clarification, these depositor-provided structures are
called “substance conformers”, and the theoretical con-
formers generated by PubChem3D for each PubChem
Compound record (unique identifier: CID) are called
“compound conformers”. For an efficient use of the Pub-
Chem3D resources, it is necessary to assign a unique
identifier to each of compound conformers in the Pub-
Chem Compound database and substance conformers in
the PubChem Substance database. The global conformer
identifier (GID) uniquely identifies each conformer and
is stored as a hex-encoded 64-bit unsigned integer,
where the first 16-bits (0x000000000000FFFF) corre-
spond to the local conformer identifier (LID), which is
specific to a given conformer ensemble, the next 16-bits
(0x00000000FFFF0000) are the version identifier (always
zero for PubChem3D compound conformers, but non-
zero for deposited substance conformers) and the last
32 bits (0xFFFFFFFF00000000) correspond to the struc-
ture identifier. This identifier is a compound identifier
(CID), if the version identifier is zero, and a substance
identifier (SID), when the version identifier is non-zero
(the version identifier indicates the substance version to
which the conformer corresponds). Substance conformer
identifiers allow deposited 3-D coordinates to be utilized
effectively by the PubChem3D system. As one can see,
the GID provides global conformer identification system
across all PubChem conformers.
A shape fingerprint is computed for the first ten
diverse conformers. To generate this property, each con-
former is ST-optimized to a set of reference conformers
that describe the entire shape space diversity of the con-
tents of PubChem3D. If the conformer is shape similar
beyond a particular threshold to a reference conformer,
the reference conformer identifier (CID and LID) and a
packed rotational/translational matrix (64-bit integer)
are retained. This makes each set reference conformer
like a bit in a binary fingerprint, however; in this case,
additional information (the superposition) is also
retained. One can imagine that these shape fingerprints
a r eal i t t l el i k ec o o r d i n a t e s in shape space, mapping
where a given conformer is located.
This shape fingerprint can be used in several ways
during 3-D similarity computation and was born out of
our earlier research [8,41] on “alignment recycling.”
This work demonstrated that similar conformers align
to a reference shape in a similar way. This means that,
if one is interested only in finding similar shapes, con-
former pairs that do not have common shape fingerprint
“bits” can be ignored (i.e., there is no need to perform a
computationally intensive conformer alignment overlap
optimization between two conformers when no com-
mon shape fingerprint reference exists, because the two
conformer shapes are dissimilar to the extent that they
may not need to be considered further). Additionally,
when a common shape fingerprint reference exists
between two conformers, one can “replay” the align-
m e n t so ft h et w oc o n f o r m e r st ot h ec o m m o nr e f e r e n c e
shape to yield a conformer alignment overlap between
conformers that is (typically) very close to the optimal
overlay; thus speeding up any conformer alignment
overlap optimization but also providing an opportunity
to further skip overlap optimization, when the best pre-
optimized alignment overlap is not sufficient.
4. Similar Conformer Neighboring Relationship
Analogous to the precomputed “Similar Compounds”
relationship for 2-D similarity, PubChem3D now pro-
vides a “Similar Conformers” neighboring relationship
[8] using 3-D similarity. This neighboring takes into
account both conformer shape similarity and conformer
pharmacophore feature similarity. Essentially, this is
equivalent to performing a shape-optimized similarity
search using ROCS [14,15] at a threshold of ST > 0.795
and CT > 0.495, when both conformers have defined
pharmacophore features. To allow for compounds
devoid of features to be neighbored, a threshold of ST >
0.925 is used, but with the caveat that both conformers
must not have any defined pharmacophore features.
Currently, three diverse conformers per compound are
neighbored; however, this may change, with up to ten
conformers per compound used as computational
resources allow. The conformers used for neighboring
correspond to the first “N” conformers in the diverse
conformer list property. (See the Conformer Model
Properties section.) This ensures maximal coverage of
the unique shape/feature space of a chemical structure
as additional conformers are considered in neighboring.
5. FTP Site
PubChem3D data is available on the PubChem FTP site
(ftp://ftp.ncbi.nlm.nih.gov/pubchem/Compound_3D).
One may download in bulk 3-D descriptions of Pub-
Chem Compound records. On average there are
approximately 110 conformers per compound in the
PubChem3D system; however, not all data is provided
for public download, in part due to the overall size
being many terabytes, more data than one can readily
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vided in various file formats (SDF, XML, and ASN.1)
that correspond to either the default conformer or the
first ten conformers in the diverse conformer list prop-
erty. (See the Conformer Model Properties section.)
Beyond these two conformer subsets of PubChem3D,
one may also find a description of the conformers that
comprise the PubChem3D shape fingerprint. These con-
formers represent all shape diversity present in the Pub-
Chem3D system for a given analytic volume range and a
given level of shape similarity ST threshold.
The “Similar Conformers” neighboring relationship is
also provided for download. This conformer pair rela-
tionship (one per line) includes the respective conformer
identifiers, ST, CT, and the 3 × 3 rotation matrix and
translation vector (applied in that order) to superimpose
the second conformer to the first. The rotation/transla-
tion refers to the coordinates provided in the download
set of ten diverse conformers or otherwise available for
download from our PubChem download facility. (See
the Utility: Download section.)
Utility
1. NCBI Entrez Interface
The primary search interface for PubChem is Entrez [4],
e.g., for the PubChem Compound database, accessible by
means of the PubChem homepage (http://pubchem.ncbi.
nlm.nih.gov) or the URL: http://www.ncbi.nlm.nih.gov/
pccompound?Db=pccompound. There are fourteen
Entrez indexes available to query PubChem Compound
records based on 3-D information detailed in Table 2.
For example, to find which compound conformer mod-
els were sampled in the RMSD range between 0.4 and
0.6, one would perform the query “0.4:0.6
[ConformerModelRmsd3D]”.
The indexes for “Volume3D”, “XStericQuadrupole3D”,
“YStericQuadrupole3D”,a n d“ZStericQuadrupole3D” cor-
respond, respectively, to the analytic volume and the three
steric quadrupole moments [9,12,42] for only the first con-
former in the diverse conformer list (i.e., the default con-
former). The steric quadrupoles essentially correspond to
the extents of the compound, where X, Y, and Z corre-
spond to the length, width, and height. For example, to
find very long, near-linear compounds, one may give the
PubChem Compound Entrez query “50:100[XSter-
icQuadrupole3D] AND 0:1[YStericQuadru-
pole3D] AND 0:1[ZStericQuadrupole3D]”.
Please note that shortcuts exist for most indexes. These
are documented in the PubChem Help “PubChem Indexes
and Filters in Entrez” section (http://pubchem.ncbi.nlm.
nih.gov/help.html#PubChem_index).
PubChem also provides filtering capabilities. Unlike
indexes, which hold discrete values, filters are Boolean-
based (i.e., either a record is in the list or it is not). Pub-
Chem3D provides some additional filtering capabilities.
In the case of the PubChem Compound database, there
is a filter “has 3d conformer” that will indicate whether
a given compound record has a 3-D conformer model
by means of the PubChem Compound query: ““has 3d
conformer"[filter]”.
Filtering capabilities were also expanded in the Pub-
Chem Substance database. Two filters were added: “has
Table 2 PubChem3D Entrez indexes
Index name Description and example query
ConformerCount3D Conformer count (e.g., for compounds with only 1-5 conformers in their ensemble: “1:5[ConformerCount3D]“)
ConformerModelRmsd3D Conformer sampling RMSD in Å (e.g., for compounds with 0.4 Å sampling RMSD: “0.4
[ConformerModelRmsd3D]“)
EffectiveRotorCount3D Effective rotor count (e.g., for compounds with 5.2-5.6 effective rotors: “5.2:5.6[EffectiveRotorCount3D]“)
FeatureCount3D Total count of individual features (e.g., for compounds with 0-4 total features: “0:4[FeatureCount3D]“)
FeatureAcceptorCount3D Hydrogen-bond acceptor count (e.g., for compounds with three acceptor features: “3
[FeatureAcceptorCount3D]“)
FeatureAnionCount3D Anion count at pH 7 (e.g., for compounds with 0-1 anion features: “0:1[FeatureAnionCount3D]“)
FeatureCationCount3D Cation count at pH 7 (e.g., for compounds with one cation feature: “1[FeatureCationCount3D]“)
FeatureDonorCount3D Hydrogen-bond donor count (e.g., for compounds with 5-11 donor features: “5:11[FeatureDonorCount3D]“)
FeatureHydrophobeCount3D Hydrophobe count (e.g., for compounds with no hydrophobe features: “0[FeatureHydrophobeCount3D]“)
FeatureRingCount3D Ring count (e.g., for compounds with 1-2 ring features: “1:2[FeatureRingCount3D]“)
Volume3D Analytic volume of the first diverse conformer (default conformer) for each compound (e.g., for volume range 110-
220.5 Å
3: “110:220.5[Volume3D]“)
XStericQuadrupole3D Qx (describes length) of the first diverse conformer (default conformer) for each compound (e.g., for Qx range 20.2-30.4
Å
5: “20.2:30.4[XStericQuadrupole3D]“)
YStericQuadrupole3D Qy (describes width) of the first diverse conformer (default conformer) for each compound (e.g., for Qy range 5.1-9.8
Å
5: “5.1:9.8[YStericQuadrupole3D]“)
ZStericQuadrupole3D Qz (describes height) of the first diverse conformer (default conformer) for each compound (e.g., for Qz range 1.3-4.2
Å
5: “1.3:4.2[ZStericQuadrupole3D]“)
Searchable compound- and conformer-specific fields available for PubChem Compound records.
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indicate when a substance record has 3-D coordinates
and when the contributed 3-D coordinates were deter-
mined experimentally, respectively. For example, to find
all experimentally determined 3-D structures for sub-
stance records, one would use the PubChem Substance
databases query: ““has deposited 3d experi
mental"[filter]”.
2. Visualization
Each PubChem Compound (and Substance) record has
a summary page as depicted in Figure 2 (http://pub-
chem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=681
for dopamine). When a 3-D conformer model can be
produced for a compound record (or a depositor-pro-
vided 3-D coordinates for the substance record), a 3-D
image of the structure will be available by clicking the
“3D” tab. In the case of a PubChem Compound record,
this corresponds to the first diverse conformer, which is
the default conformer. As shown in Figure 3, if one
clicks the image, a popup menu appears allowing one to
invoke the “Web-based 3D Viewer” or to send the 3-D
information to the “Pc3D Viewer Application”.
The Pc3D viewer application can be downloaded and
installed on PC, Mac, or Linux computers. A link to
download this application can be found below the image
on a given summary page or other PubChem3D aware
pages (e.g.,s e et h e“Pc3D Viewer Download” icon in
Figure 2). The viewer provides an interface for rendering
3-D structures of PubChem Compound records and
visualizing their superpositions. With a customizable 3-
D rendering engine that provides dynamic molecular
visualization experience, it has the ability to create high-
resolution, publication-quality images. It allows use of
XYZ model files and SDF files and supports PubChem
native formatted files (with the .pc3d or .asn extension).
The web-based 3-D viewer, like the Pc3D viewer
application, allows one to browse 3-D conformers avail-
able for substances or compounds and their superposi-
tions. This interactive tool (accessible via http://
pubchem.ncbi.nlm.nih.gov/vw3d/) operates without the
need for a web browser plug-in (and does not use Java,
for support related reasons) by means of displaying a
series of images to simulate molecule rotation. As
shown in Figure 4, besides providing immediate access
to the “Similar Conformer” neighboring relationship per
compound (and per compound conformer), users can
access various controls to perform such tasks as: super-
position or conformer navigation, data export, confor-
mer rotation type, conformer rotation speed, conformer
image resize, conformer filtering, and sorting. The
viewer allows any arbitrary set of 3-D compound con-
formers or conformer pairs (substance and compound)
that exists within PubChem to be viewed or superim-
posed. This tool is also the primary resource to visualize
and manage 3-D information from various Pub-
Chem3D-aware tools, including 3-D conformer search
and 3-D structure clustering.
3. Search
The PubChem Structure Search system [1] (accessible
via http://pubchem.ncbi.nlm.nih.gov/search/) allows one
to search the PubChem Compound database using a
chemical structure in various formats. PubChem3D adds
a new capability to this system by allowing one to per-
form a 3-D similarity search and to visualize the results.
At the time of writing, this similarity search is essen-
tially equivalent to that described in the Similar Con-
former Neighboring Relationship section. If 3-D
coordinates are not provided for a chemical structure
query, they are generated automatically, as-is possible,
while keeping in mind that not all chemical structures
can be covered by the PubChem3D system. (See the
PubChem3D Coverage section for more details.) To
aid in performing automated queries, a programmatic
interface is available. (See the Programmatic Interface
section for more details.)
A 3-D conformer search currently considers the first
three diverse conformers per compound as candidates
for “Similar Conformers”. (See diverse conformer order-
ing in the Conformer Model Properties section.) Given
that there are more than 27 million CIDs and three con-
formers per compound are being considered, this means
that there are around 81 million conformers considered
by each 3-D query. This count will change as a function
of time as data is added to PubChem and as the count
of conformers per compound are increased. To achieve
adequate query throughput, an “embarrassingly parallel
divide-and-conquer” strategy is employed. The Pub-
Chem Compound conformer data set is subdivided into
multiple evenly-sized subsets. Each subset is then
searched in parallel. If more query throughput is
desired, and the computational capacity exists, the solu-
tion is simple; one simply needs to increase the count of
evenly-sized subsets to simultaneously process.
4. Download
The PubChem Download facility [1](http://pubchem.
ncbi.nlm.nih.gov/pc_fetch) allows one to download Pub-
Chem records resulting from a search or a user-pro-
vided identifier list. With the advent of the PubChem3D
layer, there is now the ability to download up to ten
diverse conformers per compound. Alternatively, 3-D
images may be downloaded (for the default conformer,
only). A programmatic interface is available. (See the
Programmatic Interface section for more details.)
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The PubChem Score Matrix facility (http://pubchem.ncbi.
nlm.nih.gov/score_matrix) allows one to compute pairwise
similarities of a set of PubChem compound records (up to
1,000,000 similarity pairs per request). The PubChem3D
layer adds the ability to compute 3-D similarities using up
to ten conformers (either the first N-diverse conformers
or a user-provided conformer set) per compound per
request. Additionally, this service allows one to select the
type of superposition optimization (shape or feature) to
perform. A programmatic interface is available. (See the
Programmatic Interface section.)
Figure 2 Summary page enhancements. A snapshot of the PubChem Compound summary page of dopamine (CID 681). Clicking on the “3D”
tab on the right side of the page shows the 3-D structure of the molecule. Clicking the “Compound information” in the “Table of Contents” box
directs users to 2-D neighbors ("Similar Compounds”) and 3-D neighbors ("Similar Conformers”).
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The PubChem Structure Clustering tool [10] (http://
pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?p=clustering)
allows one to perform single-linkage clustering for up to
4,000 compounds at a time. This interactive tool pro-
vides visualization, subset, selection, and analysis cap-
abilities. For example, the dendrogram allows
compounds to be grouped into clusters by clicking the
Tanimoto bar provided above and below the dendro-
gram (see the bottom right panel in Figure 4). One can
then click on the cluster to view the individual com-
pounds or perform other operations. The PubChem3D
layer adds the ability to cluster compounds according to
their 3-D similarities, with up to ten diverse conformers
per compound. This service allows one to select: the
superposition optimization type (shape or feature);
Figure 3 Visualization of a 3-D structure conformer. Clicking on the 3-D image on the PubChem Compound summary page (left) shows
links to the web-based 3-D viewer (top right) and the Pc3D desktop helper application (bottom right).
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Page 9 of 15whether to cluster all conformers or just the most simi-
lar conformer pair; and the conformer similarity metric.
7. Programmatic Interface
PubChem provides a programmatic interface called the
Power User Gateway (PUG) [1]. This extends the cap-
abilities provided by the NCBI eUtils programmatic
interface [43], which interfaces the NCBI Entrez search
engine contents. PUG can be used to send programma-
tic requests (e.g., to perform queries or other tasks). If a
request does not complete, a request ID is returned.
One uses this to “poll” whether the request is com-
pleted, at which point an URL is provided to obtain the
results. This is necessary, considering that most user
requests are queued and may not be executed or com-
pleted immediately. A PUG/SOAP interface exists to
allow the SOAP-based protocol to be used to route
requests. SOAP-interfaces are readily available for most
programming (e.g., Java, C#, VisualBasic) and scripting
languages (e.g., Perl, Python), as well as workflow appli-
cations (e.g., Taverna [44], Pipeline Pilot [45]). The Pub-
Chem3D layer extensions are now available in individual
PUG-aware interfaces and by means of the PUG/SOAP
interface.
Examples of use
To assist in understanding how PubChem3D can be
useful to locate additional biological annotation and
Figure 4 Visualization of 3-D structure conformer superpositions. Superpositions between compound conformers are accessible from
various PubChem3D-aware applications. The PubChem Compound summary page (top left) allows the “Similar Conformers” neighboring
relationship to be visualized. The PubChem3D web-based viewer (bottom left) allows arbitrary superpositions to be generated. The PubChem
Structure Clustering tool (bottom right) enables all pair-wise superpositions to be examined.
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activity relationships, a series of illustrative examples
were prepared. These examples benefit from a recent
study [10] of the statistical distribution of random 3-D
similarities of more than 740,000 biologically tested
small molecules in PubChem using a single conformer
per compound, where the average (μ)a n ds t a n d a r d
deviation (s) of the shape-optimized ST, CT, and Com-
boT scores between two randomly selected conformers
were found to be 0.54 ± 0.10, 0.07 ± 0.05, and 0.62 ±
0.13, respectively. The probability of two random con-
formers having a ST-optimized similarity score greater
than or equal to the μ +2 s threshold (i.e., 0.74, 0.17,
and 0.88 for ST, CT, and ComboT, respectively) was
2%, 4%, and 3% for ST, CT, and ComboT, respectively.
This statistical information is meaningful to provide rea-
sonable 3-D similarity thresholds, whereby one can be
confident that most of the 3-D similarities between
Figure 5 3-D similarity relationship finds additional biological annotation. Comparison of the 2-D “Similar Compound” and 3-D “Similar
Conformer” neighboring relationships using dopamine to demonstrate how both neighboring relationship complement each other when
locating related chemical structures with unique biological annotation.
Figure 6 Relating biologically active compounds by means of PubChem3D. Chemical probes ML088 (CID 704205) and ML087 (CID
25199559) from PubChem BioAssay 1548 against tissue non-specific alkaline phosphatase (TNAP, GI:116734717) are not similar by 2-D similarity
but are by 3-D similarity.
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group of chemical structures with similar biological
activity and function are shown to have 3-D similarity
to each other above these thresholds, it suggests that a
common macromolecule binding interaction orientation
exists and, furthermore, that the features required for
such binding are present.
1. Finding additional biological annotation
In a data system such as PubChem, with a very uneven
amount of biological annotation, it is helpful to find
related chemical structures where more information is
known. PubChem provides two precomputed neighbor-
ing relationships to locate similar chemical structures.
The “Similar Conformers” neighboring relationship
precomputes the 3-D similarity between all chemical
structures in PubChem, while the “Similar Compounds”
neighboring relationship precomputes the 2-D similarity.
Using dopamine (CID 681) as an example, Figure 5
shows there can be relatively little commonality between
2 - Da n d3 - Ds i m i l a r i t i e s ;h o w e v e r ,b o t hr e l a t i o n s h i p s
find chemicals that are related, with the 2-D similarity
being good at finding chemical analogs of a given che-
mical while the 3-D similarity is skilled at locating mole-
cules with similar shape and similar 3-D orientation of
binding features. Therefore, use of both neighboring
relationships allows a larger number of related chemicals
to be found with associated biomedical literature (MeSH
Links), biologically tested (BioAssay Tested), or bound
to a protein 3-D structure (Protein3D Links).
Figure 7 Similarity score matrix for selected histamine H1 receptor antagonist anti-inflammatory drugs. The lower triangle of the score
matrix corresponds to the 2-D similarity computed using the PubChem fingerprint. The upper triangle corresponds to the 3-D similarity ST/CT
scores. The matrix elements in red text indicate a 2-D similarity ≥ 0.75 or 3-D similarity with ST ≥ 0.74 and ComboT ≥ 1.0. The first ten diverse
conformers per molecule were superimposed using shape-based optimization and the single conformer-pair per compound-pair with the largest
ComboT retained.
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Page 12 of 152. Relating chemical probes for same biological target
ML088 (CID 704205) and ML087 (CID 25199559),
shown in Figure 6, are chemical probes reported [46]
in a PubChem BioAssay (AID 1548) with EC50s of
6.19 μM and 0.20 μM, respectively. Both probes target
a common protein, the tissue non-specific alkaline
phosphatase (TNAP, GI 116734717), the deficiency of
which is associated with defective bone mineralization
in the form of rickets and osteomalacia. At first glance,
these two chemical structures are rather dissimilar,
with a 2-D subgraph similarity of 0.43 using the Pub-
Chem fingerprint. This suggests the two chemical
structures are unrelated to each other, giving no hint
as to why they have similar biological function and
efficacy. Using 3-D similarity, by means of the Pub-
Chem3D web-based viewer as shown in Figure 6, the
shape, feature, and combo similarities (0.80, 0.23, and
1.03 for ST, CT, and ComboT, respectively) tell a very
different story. The two chemical structures are 3-D
similar, suggesting that the two chemical structures
can adopt a similar shape and have some binding fea-
tures in a common 3-D orientation, thus helping to
relate the observed biological activity by providing a
hypothesis that the two inhibitors may bind in a simi-
lar manner. While this could be interpreted as simply
highlighting a deficiency in the PubChem 2-D similar-
ity metric, in this case, PubChem 3-D similarity com-
plements the PubChem 2-D similarity by allowing such
Figure 8 3-D superposition of selected histamine H1 receptor antagonist anti-inflammatory drugs. Although there is little 2-D similarity,
using the PubChem fingerprint, substantial 3-D similarity is found between various structurally diverse anti-inflammatory drugs.
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chemical probes.
3. Relating chemically diverse structures with same
pharmacological action
Figure 7 shows the 2-D and 3-D similarity score
matrices for a carefully selected set of eight anti-
inflammatory drug molecules having the same MeSH
[47] pharmacological action annotation of “Histamine
H1 Antagonists” (MeSH ID 68006634). Figure 8
depicts a subset of 3-D ST-optimized superpositions
resulting from the 28 unique compound pairs. The 2-
D Tanimoto similarity values between these com-
pounds are quite low, with only three compound pairs
above ≥ 0.75, indicating that the 2-D similarity method
based on the PubChem fingerprint fails to interrelate
their common biological activity as histamine H1
receptor antagonists. On the contrary, the 3-D similar-
ity between these eight molecules is rather high, with a
ST ≥ 0.74 and ComboT ≥ 1.0 for all but eight of the
28 compound pairs. As illustrated in Figure 8, even if
the 2-D Tanimoto value between a pair of molecules is
as low as 0.31, they can still have significant structural
overlap in 3-D shape/feature space, resulting in rela-
tively larger ST and CT similarity scores. The structure
clustering tool is specifically geared towards helping to
identify such structure-activity trends in 3-D similarity
(as well as 2-D similarity) space and, in combination
with the PubChem3D viewer, allow them to be visua-
lized. If one thinks about this, it shows how easy it
might be to “scaffold hop” or relate diverse chemical
structures with similar biological function by examin-
ing 3-D similar chemicals in PubChem. It may also
suggest that one may be able to better understand
additional biological functions of known drugs (i.e.,s o
called “side effects”) by examining their PubChem 3-D
similarity to other chemicals with known biological
roles.
Conclusions
A new resource for scientists, PubChem3D, layered on
top of PubChem, provides a new dimension to its ability
to search, subset, export, visualize, and analyze chemical
structures and their associated biological data. With a
broad suite of tools and capabilities, 3-D similarity is
given equal footing to assist in finding non-obvious
trends in experimentally observed biological activity. As
a complement to 2-D similarity, 3-D similarity demon-
strates a capability to relate chemical series that are not
sufficiently 2-D similar.
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